DUBLIN--(BUSINESS WIRE)--The "The Market for In Vitro Diagnostic Tests in Latin America: Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and Other Nations" report has been added to ResearchAndMarkets.com's offering.
The maturation of in vitro diagnostic (IVD) markets in developed countries have IVD companies casting their nets in developing countries where rising incomes and standards of living are anticipated to spark a new, health-consciousness population with growing demands for quality medical care. Latin America (LATAM) is a key target for IVD manufacturers.
This report focuses on the market for reagents and instruments in the major countries of the continent.
The Total LATAM Market
Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are singled out for a deeper level of analysis. The countries of Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Nicaragua, Panama, Paraguay, and Uruguay are also considered, to provide a complete overview of the region.
The report includes the following total market information:
- IVD Market in Latin America, 2018-2023
- Latin America IVD Market by Country (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela, Other LATAM), 2018-2023
- Average Growth of Latin America IVD Market by Country (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela, Other LATAM), 2018 to 2023
- Health Spending as a Percent of GDP by LATAM Country, 2018 (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela, Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Nicaragua, Panama, Paraguay, Uruguay)
Assessment of Markets by Country
As previously noted, the report takes a deep dive into the IVD markets of Argentina, Brazil, Chile, Colombia, Mexico, Peru, and Venezuela. This analysis includes the following data points for each country:
- IVD Market by Sector, 2018-2023 (General Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry) in $US thousands
- IVD Market Distribution by Sector (%; General Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry), 2018
- Average Growth of IVD Markets (CAGR 2018 to 2023), % (Clinical General Chemistry, Critical Care - Rapid, Urine Tests, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking (Inf. Dis.Scr + Imm.Typ.), Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose, Other POC, Primary Histology, Advanced Histology (IHC, ISH, FISH), Hematology, Coagulation, Flow Cytometry)
- Clinical Chemistry Market by Segment (general chemistries, critical care, urinalysis), Estimate and Forecast, 2018-2023 $US thousands
- Immunoassay Market by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2018-2023 $US thousands
- Microbiology Market by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2018-2023 $US thousands
- POC Market by Segment (glucose, other), Estimate and Forecast, 2018-2023 $US thousands
- Histology Market, by Segment (primary, advanced) Estimate and Forecast, 2018-2023 $US thousands
- Hematology Market, Estimate and Forecast, 2018-2023 $US thousands
- Coagulation Market, Estimate and Forecast, 2018-2023 $US thousands
- Flow Cytometry Market, Estimate and Forecast, 2018-2023 $US thousands
Competitive Landscape
Population growth, government insurance, newly insured patients and updated healthcare facilities will drive growth in the IVD Market in Latin America, attracting the major players in the IVD industry. Roche currently holds the largest percentage of the IVD market in Latin America, with the top five companies participating in the market making up over 60% of the market.
The Market for In Vitro Diagnostic Tests in Latin America presents market share of leading players:
- IVD Market Share in Latin America, by Company (%), 2018
- Latin American Market Leaders in Selected Segments (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays, Immunoassays Microbiology, Microbiology, Molecular Infectious Disease, Histology, Hematology, Coagulation, Flow Cytometry)
Further, the report provides market participant share by country for Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela by the following IVD market segments:
- Clinical Chemistry Market, Market Participant Share (%), 2018
- Critical Care Market, Market Participant Share (%), 2018
- Urinalysis Market, Market Participant Share (%), 2018
- Immunoassay Market, Market Participant Share (%), 2018
- Microbiology Immunoassay Market, Market Participant Share (%), 2018
- Immunoassay (non-Microbiology) Market, Market Participant Share (%), 2018
- Blood Banking Market, Market Participant Share (%), 2018
- Microbiology Market, Market Participant Share (%), 2018
- ID/AST Market, Market Participant Share (%), 2018
- Molecular Microbiology and Nucleic Acid Test Market, Market Participant Share (%), 2018
- POC Market, Market Participant Share (%), 2018
- POC Glucose Testing Market, Market Participant Share (%), 2018
- Histology Market, Market Participant Share (%), 2018
- Hematology Market, Market Participant Share (%), 2018
- Coagulation Market, Market Participant Share (%), 2018
- Flow Cytometry Market, Market Participant Share (%), 2018
Market Opportunity by Country Evaluated
Since all the countries in Latin America vary in size, healthcare infrastructure and affordability, in vitro diagnostic companies need to tailor strategies for approaching each country's market. Tailored strategies are needed for each different country and will assure success if they are conscientiously planned.
The report evaluates the market environments in Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela, assessing the strength of the market opportunity based on the following factors:
- Population Size
- Aging Population Size
- Aging Population Growth
- Diabetes Prevalence Rate
- Poverty Rate
- Inflation Rate
- GDP Spending on Health
- IVD Market Size
- IVD Market Growth Rate
- Competitive Intensity
- Political/Economic Stability
- Technology Demand
- Regulatory System Process
For more information about this report visit https://www.researchandmarkets.com/research/cl6llh/the_market_for_in?w=4
